Jennison Associates LLC Amgen Inc Transaction History

Jennison Associates LLC

$160 Billion
Q3 2024

A detailed history of Jennison Associates LLC transactions in Amgen Inc stock. As of the latest transaction made, Jennison Associates LLC holds 579,465 shares of AMGN stock, worth $153 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

579,465

Previous 658,224 11.97%

Holding current value

$153 Million

Previous $206 Million 9.22%

% of portfolio

0.12%

Previous 0.13%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $24.4 Million - $26.6 Million	-78,759 Reduced 11.97%	579,465 $187 Million
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $27.8 Million - $33.8 Million	105,710 Added 19.13%	658,224 $206 Million
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $26.4 Million - $31.8 Million	-98,123 Reduced 15.08%	552,514 $157 Million
Q4 2023 Feb 01, 2024	BUY	$255.7 - $288.46 $111 Million - $125 Million	432,871 Added 198.78%	650,637 $187 Million
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $20.8 Million - $25.8 Million	95,027 Added 77.42%	217,766 $58.5 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $44.9 Million - $53.1 Million	-209,687 Reduced 63.08%	122,739 $27.3 Million
Q1 2023 Apr 26, 2023	BUY	$225.79 - $275.2 $1.53 Million - $1.86 Million	6,768 Added 2.08%	332,426 $80.4 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $35.5 Million - $45 Million	154,786 Added 90.59%	325,658 $85.5 Million
Q3 2022 Nov 01, 2022	BUY	$224.46 - $253.15 $738,922 - $833,369	3,292 Added 1.96%	170,872 $38.5 Million
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $38.7 Million - $43 Million	167,580 New	167,580 $40.8 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $1.35 Million - $1.58 Million	-6,357 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $140,848 - $156,261	603 Added 10.48%	6,357 $1.55 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $1.28 Million - $1.49 Million	5,754 New	5,754 $1.43 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $4.67 Million - $5.56 Million	-21,567 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $3.74 Million - $4.15 Million	15,921 Added 281.99%	21,567 $5.48 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $828,428 - $1.02 Million	-4,188 Reduced 42.59%	5,646 $1.33 Million
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $996,306 - $1.32 Million	-5,467 Reduced 35.73%	9,834 $1.99 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $351,552 - $451,865	1,858 Added 13.82%	15,301 $3.69 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $1.11 Million - $1.33 Million	-6,373 Reduced 32.16%	13,443 $2.6 Million
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $78,349 - $91,842	-470 Reduced 2.32%	19,816 $0
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $3.67 Million - $4.14 Million	20,286 New	20,286 $3.85 Million
Q1 2018 Apr 20, 2018	SELL	$169.43 - $198.0 $12.6 Million - $14.7 Million	-74,421 Closed	0 $0
Q4 2017 Jan 25, 2018	SELL	$168.79 - $188.59 $19.5 Million - $21.8 Million	-115,330 Reduced 60.78%	74,421 $12.9 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $31.7 Million - $36.2 Million	189,751	189,751 $35.4 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Amgen Inc Transaction History